-+ 0.00%
-+ 0.00%
-+ 0.00%

Processa Pharmaceuticals FY2025 net loss widened 14.46% to USD 13.56 million as general and administrative expenses rose 29.19% to USD 6.18 million

Reuters·03/18/2026 20:08:44

Please log in to view news